Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life.

Laughton, Barbara; Naidoo, Shalena; Dobbels, Els F M T; Boivin, Michael J; van Rensburg, Anita Janse; Glashoff, Richard H; van Zyl, Gert U; Kruger, Mariana; Cotton, Mark F

Laughton, Barbara; Naidoo, Shalena; Dobbels, Els F M T; Boivin, Michael J; van Rensburg, Anita Janse; Glashoff, Richard H; van Zyl, Gert U; Kruger, Mariana; Cotton, Mark F.

Afiliación

Laughton B; Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Naidoo S; Department of Pathology, Stellenbosch University, Cape Town, South Africa.
Dobbels EFMT; Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Boivin MJ; Department of Psychiatry, Michigan State University, East Lansing, United States.
van Rensburg AJ; Department of Neurology and Ophthalmology, Michigan State University, East Lansing, United States.
Glashoff RH; Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
van Zyl GU; Department of Pathology, Stellenbosch University, Cape Town, South Africa.
Kruger M; National Laboratory Services, Cape Town, South Africa.
Cotton MF; National Laboratory Services, Cape Town, South Africa.

South Afr J HIV Med ; 20(1): 1008, 2019.

Article en En | MEDLINE | ID: mdl-31745434

Palabras clave

HIV; antiretroviral therapy; infants; neurodevelopment; paediatrics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: South Afr J HIV Med Año: 2019 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Sudáfrica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google